Skip to content
HowShorted

Cabaletta Bio, Inc. short interest in 2023

In 2023, Cabaletta Bio, Inc.'s disclosed short interest ran from 11.27% of shares outstanding on 13 Jan 2023 to 14.51% on 29 Dec 2023, a change of +3.24 percentage points. The year's high was 17.59% on 14 Jul 2023 and its low 7.88% on 15 Sep 2023, averaging 12.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.54 days on 14 Apr 2023. Full history: Cabaletta Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cabaletta Bio, Inc. in 2023

2023 in figures

Start of year
11.27% (13 Jan 2023)
End of year
14.51% (29 Dec 2023)
Change
+3.24 pp
High
17.59% (14 Jul 2023)
Low
7.88% (15 Sep 2023)
Average
12.99%
Highest days to cover
18.54 (14 Apr 2023)
SEC filings marked
8

Every report in 2023

Cabaletta Bio, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202311.27%5.10
31 Jan 202311.67%3.90
15 Feb 202311.66%5.10
28 Feb 202311.99%5.92
15 Mar 202311.38%10.89
31 Mar 202311.75%13.1810-K filed, results (8-K)
14 Apr 202312.89%18.54
28 Apr 202312.76%15.96
15 May 202312.70%8.8910-Q filed, results (8-K)
31 May 202312.81%8.38
15 Jun 202313.72%13.84
30 Jun 202316.79%4.99
14 Jul 202317.59%16.15
31 Jul 202316.11%11.09
15 Aug 202313.47%16.3810-Q filed, results (8-K)
31 Aug 20238.18%9.13
15 Sep 20237.88%2.31
29 Sep 202313.03%6.48
13 Oct 202315.55%7.19
31 Oct 202315.79%11.52
15 Nov 202311.80%7.9110-Q filed, results (8-K)
30 Nov 202313.24%2.18
15 Dec 202313.15%3.41
29 Dec 202314.51%6.89

See also: Cabaletta Bio, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.